Skip to content

Nutex Health and Affiliated Hospitals Announce Groundbreaking Postpartum Depression Treatment

Camille Cox

Director of Marketing

ccox@nutexhealth.com

FOR IMMEDIATE RELEASE   

.

Houston, TX, Oct. 3, 2019, —Nutex Health is proud to offer a new, revolutionary treatment for postpartum depression at all our affiliated hospitals. The beneficial drug, Zulresso, is now available at the facility and can relieve women of postpartum depression symptoms in as little as 24 hours. The treatment is given through an IV and must be administered in-house at a Nutex affiliated hospital.

Zulresso helps ease both emotional and physical symptoms of postpartum depression. This treatment helps reduce feelings of hopelessness, rage, anxiousness, or thoughts of harming yourself or your baby. As well as alleviate symptoms like body aches and pains, changes in appetite, and issues sleeping or oversleeping.

Over 90 percent of the women whose symptoms decreased with Zulresso still felt better 30 days after the treatment. Having an accessible, fast-acting treatment with sustainable results is a massive victory for postpartum depression medication.

About 1 in 7 women will experience postpartum depression after giving birth, and we are thrilled to offer an advanced solution for the women in our communities facing this common condition.

Nutex Health takes pride in offering the latest techniques and treatments for all your medical needs. All our premier facilities provide concierge-level care 24/7, 365 days a year. For more information, please contact Camille Cox, Director of Marketing.